Incidence of occult lymph node metastases in pathological stage C (pT3N0) prostate cancer. 1995

J A Freeman, and D Esrig, and G D Grossfeld, and J P Stein, and S C Chen, and L L Young, and C R Taylor, and D G Skinner, and G Lieskovsky, and R J Cote
Department of Urology, University of Southern California School of Medicine, Los Angeles, USA.

OBJECTIVE To determine the incidence of occult lymph node metastases in patients with stage pT3N0 prostate cancer. METHODS Lymph nodes from 95 patients with stage pT3N0 prostate cancer were analyzed by immunohistochemistry for extrinsic epithelial cells using epithelial-specific monoclonal antibodies. The extrinsic epithelial cells were also tested for prostate specific antigen expression. RESULTS Occult lymph node metastases were identified in 15 cases (16%) and were more frequent in patients with high primary Gleason grade tumors and seminal vesicle invasion (p = 0.03). In all cases the extrinsic cells were of prostate origin based on prostate specific antigen expression. CONCLUSIONS Occult lymph node metastases can be detected in a substantial proportion of patients with stage pT3N0 prostate cancer, are associated with known predictors of disease progression, and may be useful in identifying patients at risk for recurrence and progression.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates

Related Publications

J A Freeman, and D Esrig, and G D Grossfeld, and J P Stein, and S C Chen, and L L Young, and C R Taylor, and D G Skinner, and G Lieskovsky, and R J Cote
June 2003, The New England journal of medicine,
J A Freeman, and D Esrig, and G D Grossfeld, and J P Stein, and S C Chen, and L L Young, and C R Taylor, and D G Skinner, and G Lieskovsky, and R J Cote
October 2007, Nature clinical practice. Urology,
J A Freeman, and D Esrig, and G D Grossfeld, and J P Stein, and S C Chen, and L L Young, and C R Taylor, and D G Skinner, and G Lieskovsky, and R J Cote
June 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J A Freeman, and D Esrig, and G D Grossfeld, and J P Stein, and S C Chen, and L L Young, and C R Taylor, and D G Skinner, and G Lieskovsky, and R J Cote
June 2018, The Journal of urology,
J A Freeman, and D Esrig, and G D Grossfeld, and J P Stein, and S C Chen, and L L Young, and C R Taylor, and D G Skinner, and G Lieskovsky, and R J Cote
November 2005, Gynecologic oncology,
J A Freeman, and D Esrig, and G D Grossfeld, and J P Stein, and S C Chen, and L L Young, and C R Taylor, and D G Skinner, and G Lieskovsky, and R J Cote
June 1993, The Journal of urology,
J A Freeman, and D Esrig, and G D Grossfeld, and J P Stein, and S C Chen, and L L Young, and C R Taylor, and D G Skinner, and G Lieskovsky, and R J Cote
January 2020, American journal of otolaryngology,
J A Freeman, and D Esrig, and G D Grossfeld, and J P Stein, and S C Chen, and L L Young, and C R Taylor, and D G Skinner, and G Lieskovsky, and R J Cote
April 1994, The Journal of urology,
J A Freeman, and D Esrig, and G D Grossfeld, and J P Stein, and S C Chen, and L L Young, and C R Taylor, and D G Skinner, and G Lieskovsky, and R J Cote
August 2007, European urology,
J A Freeman, and D Esrig, and G D Grossfeld, and J P Stein, and S C Chen, and L L Young, and C R Taylor, and D G Skinner, and G Lieskovsky, and R J Cote
September 1997, Annals of surgical oncology,
Copied contents to your clipboard!